Literature DB >> 16290055

Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

E de Bree1, W Koops, R Kröger, S van Ruth, V J Verwaal, F A N Zoetmulder.   

Abstract

AIM: A survival benefit has been observed for colorectal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery with intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC). However, this treatment modality is associated with a considerable morbidity and mortality and in a significant number of patients survival is not improved. We studied whether poor survivors could be identified on preoperative computed tomography (CT), in order to avoid unnecessary surgery. PATIENTS AND METHODS: Films of abdominopelvic CT scans from 25 such patients treated by cytoreductive surgery and HIPEC were retrospectively analysed by two radiologists separately. A simplified peritoneal cancer index (SPCI) was used to determine the extent of peritoneal involvement. Correlation between the on preoperative CT based SPCI-scores as well as number of involved abdominopelvic areas (N) and survival was examined with the log-rank test. The relation between each affected region and survival was evaluated with Cox regression analysis.
RESULTS: The preoperative SPCI- and N-scores of one of the radiologists had no statistically significant prognostic value, while for the second radiologist SPCI > or = 7 and N > or = 4 were associated with particularly poor outcome. Additionally, the presence of ileocaecal region involvement and, depending on the radiologist, the occurrence of tumour deposits in the left subdiaphragmatic area on CT appeared to be unfavourable prognostic signs.
CONCLUSIONS: The prognostic value of preoperative conventional CT appeared to be radiologist dependent and may, therefore, be of limited value in selecting colorectal cancer patients with peritoneal carcinomatosis who will not benefit from extensive cytoreductive surgery followed by HIPEC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16290055     DOI: 10.1016/j.ejso.2005.09.016

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  19 in total

1.  [Scoring systems for clinical staging of peritoneal carcinomatosis. A critical analysis].

Authors:  J Jähne; S Kübler
Journal:  Chirurg       Date:  2007-12       Impact factor: 0.955

2.  Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms.

Authors:  P Dubé; L Sideris; C Law; L Mack; E Haase; C Giacomantonio; A Govindarajan; M K Krzyzanowska; P Major; Y McConnell; W Temple; R Younan; J A McCart
Journal:  Curr Oncol       Date:  2015-04       Impact factor: 3.677

3.  Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC).

Authors:  Mariangela Desantis; Jean-Louis Bernard; Vincent Casanova; Marianne Cegarra-Escolano; Emmanuel Benizri; Amine M Rahili; Daniel Benchimol; Jean-Marc Bereder
Journal:  Langenbecks Arch Surg       Date:  2014-10-16       Impact factor: 3.445

4.  A feasibility study of the use of computed virtual chromoendoscopy for laparoscopic evaluation of peritoneal metastases.

Authors:  Haythem Najah; Réa Lo Dico; Anthony Dohan; Lucy Marry; Clarisse Eveno; Marc Pocard
Journal:  Surg Endosc       Date:  2016-06-20       Impact factor: 4.584

5.  Morbidity and mortality of 109 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC) performed at a community hospital.

Authors:  Alexander G Kerscher; Jared Mallalieu; Allison Pitroff; Friderike Kerscher; Jesus Esquivel
Journal:  World J Surg       Date:  2010-01       Impact factor: 3.352

6.  Selection of patients and staging of peritoneal surface malignancies.

Authors:  Eddy Cotte; Guillaume Passot; François-Noël Gilly; Olivier Glehen
Journal:  World J Gastrointest Oncol       Date:  2010-01-15

7.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignant disease.

Authors:  Wenceslao Vásquez Jiménez; Luis González Bayón; José Luis García-Sabrido; Santiago González Moreno
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

8.  Single-incision flexible endoscopy (SIFE) for detection and staging of peritoneal carcinomatosis.

Authors:  Haythem Najah; Réa Lo Dico; Marion Grienay; Anthony Dohan; Xavier Dray; Marc Pocard
Journal:  Surg Endosc       Date:  2015-12-10       Impact factor: 4.584

Review 9.  Diagnostic Laparoscopy in the Pre-operative Assessment of Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancies.

Authors:  Ramakrishnan Ayloor Seshadri
Journal:  Indian J Surg Oncol       Date:  2016-01-11

Review 10.  Peritoneal Carcinomatosis from Colon Cancer: A Systematic Review of the Data for Cytoreduction and Intraperitoneal Chemotherapy.

Authors:  Ashlie Nadler; J Andrea McCart; Anand Govindarajan
Journal:  Clin Colon Rectal Surg       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.